Paeds Cases · professional-practice-and-evidence
Explaining a treatment's risks and benefits — OSCE
OSCE on communicating the risks and benefits of a preventive medication to parents using evidence-based risk-communication tools, with attention to framing, numeracy, uncertainty and teach-back.
On this page & tools
Target exams
Station brief (8–10 minutes)
Help the parents decide whether to start the preventive medication by communicating the benefit and the rare harm accurately. Address their concern about the online "50%" figure and their numeracy and language needs. Do not invent jurisdiction-specific thresholds or specific survival statistics. [1]
Tasks for the candidate
- Assess what the family already understands and their numeracy and language needs. [14]
- Reframe the "50%" figure with the absolute baseline and absolute risk reduction. [1] [10]
- Present benefit and harm in natural frequencies with a consistent denominator and a pictograph or drug-facts box. [4] [6]
- Name the uncertainty honestly and balance the framing in both directions. [4] [13]
- Confirm understanding with teach-back, agree a plan, and arrange follow-up and a written summary. [13] [14]
Expected performance
Must hit. Baseline understanding and numeracy assessed; absolute baseline stated before any relative figure; natural frequencies with one consistent denominator plus a pictograph or drug-facts box; benefits and harms balanced bidirectionally; uncertainty named; teach-back confirms understanding; written summary and follow-up arranged; trained interpreter used. [1] [4] [14]
Merit. Acknowledges the online figure without dismissing the parent; uses a validated decision aid for the preference-sensitive choice; gives a range rather than false precision; includes the child developmentally where appropriate. [6] [13]
Fail. Quotes the 50% relative figure alone; switches denominators; frames only the benefit; offers a single false-precise estimate; no teach-back, summary or follow-up; uses a family member as interpreter. [1] [14]
Sample candidate structure
“Thank you both for coming in, and I'll use the interpreter throughout so we're all clear. First, tell me what you have read about this medicine and what you understand so far. … The '50%' figure you saw is a relative reduction, and on its own it can look bigger than it is. Let me show you the actual numbers. Out of 1000 children like yours, about 2 would have this problem without the medicine, and about 1 with it — that is the real size of the benefit. Here is a picture of it. There is also a rare side effect, and I want to show you that side by side, in the same terms, so you can weigh them together. What questions do you have? Let's check we're together: can you tell me, in your own words, what the benefit and the risk look like to you?” [1] [4] [6]
References
- [1]Gigerenzer G Helping Doctors and Patients Make Sense of Health Statistics. Psychological science in the public interest, 2007.PMID 26161749
- [4]Zipkin DA Evidence-based risk communication: a systematic review. Annals of internal medicine, 2014.PMID 25133362
- [6]Schwartz LM Using a drug facts box to communicate drug benefits and harms: two randomized trials. Annals of internal medicine, 2009.PMID 19221371
- [10]Moxey A Describing treatment effects to patients. Journal of general internal medicine, 2003.PMID 14687282
- [13]Peters E Communicating Numeric Risk Information to Patients. Journal of general internal medicine, 2025.PMID 40301218
- [14]Levetown M Communicating with children and families: from everyday interactions to skill in conveying distressing information. Pediatrics, 2008.PMID 18450887